- Home
- SPT vs EVO Comparison
SPT vs EVO Comparison
Compare SPT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPT
- EVO
- Stock Information
- Founded
- SPT 2010
- EVO 1993
- Country
- SPT United States
- EVO Germany
- Employees
- SPT N/A
- EVO N/A
- Industry
- SPT Computer Software: Prepackaged Software
- EVO Biotechnology: Pharmaceutical Preparations
- Sector
- SPT Technology
- EVO Health Care
- Exchange
- SPT Nasdaq
- EVO Nasdaq
- Market Cap
- SPT 1.8B
- EVO 1.6B
- IPO Year
- SPT 2019
- EVO 2021
- Fundamental
- Price
- SPT $32.45
- EVO $4.44
- Analyst Decision
- SPT Buy
- EVO Buy
- Analyst Count
- SPT 15
- EVO 2
- Target Price
- SPT $46.92
- EVO $5.90
- AVG Volume (30 Days)
- SPT 591.9K
- EVO 238.2K
- Earning Date
- SPT 02-18-2025
- EVO 11-06-2024
- Dividend Yield
- SPT N/A
- EVO N/A
- EPS Growth
- SPT N/A
- EVO N/A
- EPS
- SPT N/A
- EVO N/A
- Revenue
- SPT $392,402,000.00
- EVO $866,665,179.00
- Revenue This Year
- SPT $22.78
- EVO $4.56
- Revenue Next Year
- SPT $14.99
- EVO $13.44
- P/E Ratio
- SPT N/A
- EVO N/A
- Revenue Growth
- SPT 26.70
- EVO N/A
- 52 Week Low
- SPT $25.05
- EVO $2.85
- 52 Week High
- SPT $68.41
- EVO $12.00
- Technical
- Relative Strength Index (RSI)
- SPT 51.29
- EVO 45.00
- Support Level
- SPT $33.62
- EVO $4.39
- Resistance Level
- SPT $36.30
- EVO $4.81
- Average True Range (ATR)
- SPT 1.87
- EVO 0.14
- MACD
- SPT -0.21
- EVO -0.07
- Stochastic Oscillator
- SPT 33.39
- EVO 0.00
About SPT Sprout Social Inc
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. The firm generates majority revenue from software subscriptions.
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.